» Articles » PMID: 33488753

Advances in Pharmacological Actions and Mechanisms of Flavonoids from Traditional Chinese Medicine in Treating Chronic Obstructive Pulmonary Disease

Overview
Date 2021 Jan 25
PMID 33488753
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic obstructive pulmonary disease (COPD) is a common respiratory disease with high morbidity and mortality. The conventional therapies remain palliative and have various undesired effects. Flavonoids from traditional Chinese medicine (TCM) have been proved to exert protective effects on COPD. This review aims to illuminate the poly-pharmacological properties of flavonoids in treating COPD based on laboratory evidences and clinical data and points out possible molecular mechanisms. Animal/laboratory studies and randomised clinical trials about administration of flavonoids from TCM for treating COPD from January 2010 to October 2020 were identified and collected, with the following terms: chronic obstructive pulmonary disease or chronic respiratory disease or inflammatory lung disease, and flavonoid or nature product or traditional Chinese medicine. Pharmacokinetic studies and external application treatment were excluded. A total of 15 flavonoid compounds were listed. Flavonoids could inhibit inflammation, oxidative stress, and cellular senescence, restore corticosteroid sensitivity, improve pulmonary histology, and boost pulmonary function through regulating multiple targets and signaling pathways, which manifest that flavonoids are a group of promising natural products for COPD. Nevertheless, most studies remain in the research phase of animal testing, and further clinical applications should be carried out.

Citing Articles

Association of dietary flavonoid intakes with prevalence of chronic respiratory diseases in adults.

Wu R, Zhu X, Guan G, Cui Q, Zhu L, Xing Y J Transl Med. 2024; 22(1):205.

PMID: 38409037 PMC: 10898189. DOI: 10.1186/s12967-024-04949-7.


The therapeutic potential of quercetin for cigarette smoking-induced chronic obstructive pulmonary disease: a narrative review.

Ding K, Jiang W, Zhan W, Xiong C, Chen J, Wang Y Ther Adv Respir Dis. 2023; 17:17534666231170800.

PMID: 37154390 PMC: 10170608. DOI: 10.1177/17534666231170800.


Effects of Ipratropium Bromide Combined with Traditional Chinese Medicine Intervention on the Pulmonary Function and Psychological Status of Patients with Chronic Obstructive Pulmonary Disease.

Ye W, Zhao H, Ye J, Sang H, Zhou L, Lv J Evid Based Complement Alternat Med. 2023; 2023:6483785.

PMID: 36798728 PMC: 9928514. DOI: 10.1155/2023/6483785.


Gou Qi Zi inhibits proliferation and induces apoptosis through the PI3K/AKT1 signaling pathway in non-small cell lung cancer.

Zhang L, Gong Y, Zhang L, Liang B, Xu H, Hu W Front Oncol. 2023; 12:1034750.

PMID: 36591458 PMC: 9796997. DOI: 10.3389/fonc.2022.1034750.


Chemical Structures and Pharmacological Properties of Typical Bioflavonoids in (PGR).

Luo M, Hu Z, Zhong Z, Liu L, Lin C, He Q J Environ Public Health. 2022; 2022:4649614.

PMID: 36570783 PMC: 9788903. DOI: 10.1155/2022/4649614.


References
1.
Traboulsi H, Cloutier A, Boyapelly K, Bonin M, Marsault E, Cantin A . The Flavonoid Isoliquiritigenin Reduces Lung Inflammation and Mouse Morbidity during Influenza Virus Infection. Antimicrob Agents Chemother. 2015; 59(10):6317-27. PMC: 4576023. DOI: 10.1128/AAC.01098-15. View

2.
Kuwano K, Araya J, Hara H, Minagawa S, Takasaka N, Ito S . Cellular senescence and autophagy in the pathogenesis of chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). Respir Investig. 2016; 54(6):397-406. DOI: 10.1016/j.resinv.2016.03.010. View

3.
Boukhenouna S, Wilson M, Bahmed K, Kosmider B . Reactive Oxygen Species in Chronic Obstructive Pulmonary Disease. Oxid Med Cell Longev. 2018; 2018:5730395. PMC: 5828402. DOI: 10.1155/2018/5730395. View

4.
Khorasani N, Baker J, Johnson M, Chung K, Bhavsar P . Reversal of corticosteroid insensitivity by p38 MAPK inhibition in peripheral blood mononuclear cells from COPD. Int J Chron Obstruct Pulmon Dis. 2015; 10:283-91. PMC: 4322842. DOI: 10.2147/COPD.S72403. View

5.
Barnes P . Senescence in COPD and Its Comorbidities. Annu Rev Physiol. 2016; 79:517-539. DOI: 10.1146/annurev-physiol-022516-034314. View